MolMed Company Profile: Acquisition & Investors

MolMed Overview

Founded
1996

Status
Acquired/Merged

Employees
223

Latest Deal Type
M&A

Financing Rounds
7

Investments
1

MolMed General Information

Description

Molmed SpA is an Italy based medical biotechnology company. It is engaged in research, development and clinical validation of innovative therapies to treat cancer. The company's therapies include TK for blood cancers and NGR-hTNF for solid tumors. Its pipeline includes antitumor therapeutics in clinical and preclinical development.

Contact Information

Website

www.molmed.com

Ownership Status

Acquired/Merged

Financing Status

Formerly PE-Backed

Primary Industry

Biotechnology

Other Industries

Discovery Tools (Healthcare)

Acquirer

AGC Biologics

Primary Office

Via Olgettina 58
20132 Milan
Italy

+39 0000000



Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MolMed Valuation & Funding

Deal Type	Date	Amount	Valuation/ EBITDA	Post-Val	Status	Debt

This information is available in the PitchBook Platform. To explore MolMed‘s full profile, request access.

Request a free trial

MolMed Comparisons

Description

Primary
Industry

HQ Location

Employees

Total Raised

Post Valuation

Last Financing Details

Molmed SpA is an Italy based medical biotechnology company. It is engaged in research, development and clinical validati

Biotechnology

Milan, Italy

223 As of 2020

00000

0000 0000-00-00

000000&0 00000

00000

gna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea

0000000000000

Cambridge, MA

000 As of 0000

00000

000000&0

000000 0

nsequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat null

0000 000000000

Amsterdam, Netherlands

000 As of 0000

00000

0000 0000-00-00

000000&0 00000

Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

MolMed Competitors (2)

Company Name	Financing Status	Location	Employees	Total Raised	Last Financing Date/Type	Last Financing Amount
Agios	Formerly VC-backed	Cambridge, MA	000	00000	000000&0
000000 000000	Formerly VC-backed	Amsterdam, Netherlands	000	00000	000000&0	00000

You’re viewing 2 of 2 competitors. Get the full list »

MolMed Patents

6
Total Documents Applications and Grants
000
Total Patents Families
000
Granted
000
Pending
000
Expiring in next 12 mo

MolMed Recent Patent Activity

Publication ID	Patent Title	Status	First Filing Date	Technology (CPC)
DE-69916829-D1	Genetically modified fibroblasts and their use	Expired - Fee Related	08-May-1998	0000000000
EP-1084232-B1	Genetically-modified fibroblasts and the use thereof	Expired - Lifetime	08-May-1998	0000000000
EP-1084232-A1	Genetically-modified fibroblasts and the use thereof	Granted	08-May-1998	0000000000
AU-4037299-A	Genetically-modified fibroblasts and the use thereof	Abandoned	08-May-1998	0000000000
CA-2331826-A1	Genetically-modified fibroblasts and the use thereof	Abandoned	08-May-1998	C12N5/0658